At BioLaurus, we take pride in our expertise and specialization in the niche field of preclinical molecular imaging. Your needs are important to us – not just as a study, but as a scientific partner as well. We strive for excellence across all performance platforms – scientific, relational and budgetary. And we deliver. BioLaurus offers longitudinal studies, small animal and non-human primate preclinical animal imaging (NHP), microdialysis, gene expression, cell assays, and other services to meet your preclinical study needs. Below is a list of our capabilities:

Services & Solutions
• Study Design
• Imaging Assay Development
• Gene Expression
• Safety Pharmacology
• Imaging Toxicology (iTox™)
• In Vivo Efficacy
• Mechanism of Action
• Disease Staging
• PK/PD
• Biodistribution
• Fluorescence chemistry
• NASH Model
• mU-Opioid Receptor studies
• Platelet Sequestration Studies
• Radiochemistry (from Tc-99m to Zr-89)
• C-11, F-18 (cyclotron)
• C-14 and H-3 labeling

Imaging Modalities
• SPECT
• PET
• CT
• Micro-CT
• MRI
• Ultrasound
• Optical Imaging
• BLI (BioLuminescence Imaging)
• FLI (Fluorescence Imaging)
• FLIM (Fluorescence Lifetime Imaging)

Quantitative Image Analysis
• Receptor Binding Kinetics (Pharmacokinetics)
• PD analytics (Pharmacodynamics)
• Cell tracking/persistence
• Bone morphometry

Therapeutic Indications
• Oncology
• Central Nervous System
• Immune Therapeutics
• Stem Cell Therapeutics
• Platelet Activation/Survival
• Cardiovascular
• Pulmonary
• Bone Regeneration
• Gastro-intestinal